TYMS and prostate carcinoma: TYMS overexpression is associated with poor disease-specific survival and local recurrence-free survival of various solid tumors such as lung cancer (Ding et al.,2020), gastric cancer (Cao et al.,2017) and prostate cancer (Burdelski et al.,2015).